240 related articles for article (PubMed ID: 4996475)
1. Newer hypolipidemic agents.
Kritchevsky D
Fed Proc; 1971; 30(3):835-40. PubMed ID: 4996475
[No Abstract] [Full Text] [Related]
2. [Enzyme-inducing activities of hypolipidemic agents and ultrastructural changes of the liver elicited by clofibrate (author's transl)].
Araki Y; Amagase H
Fukuoka Igaku Zasshi; 1974 Jul; 65(7):465-72. PubMed ID: 4474120
[No Abstract] [Full Text] [Related]
3. Effects of selected hypolipidemic drugs on cell ultrastructure.
Svoboda DJ; Azarnoff DL
Fed Proc; 1971; 30(3):841-7. PubMed ID: 5575296
[No Abstract] [Full Text] [Related]
4. Effect of SaH 42-348, an analog of clofibrate, on lipid metabolism in rats.
Kritchevsky D; Tepper SA
Arzneimittelforschung; 1973 Jun; 23(6):858-9. PubMed ID: 4740771
[No Abstract] [Full Text] [Related]
5. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
Kokatnur MG; Malcom GT
Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
[No Abstract] [Full Text] [Related]
6. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
[No Abstract] [Full Text] [Related]
7. Structure-activity relationships in membrane-perturbing agents. Hemolytic, narcotic, and antibacterial compounds.
Hansch C; Glave WR
Mol Pharmacol; 1971 May; 7(3):337-54. PubMed ID: 5106355
[No Abstract] [Full Text] [Related]
8. [Pharmacologic study of a hypocholesteremic agent (MG. 46)].
Nordmann J; Loiseau G; Berthe G; Lohier P; Truchaud M
Therapie; 1972; 27(2):339-58. PubMed ID: 4673514
[No Abstract] [Full Text] [Related]
9. [Pharmacology of probucol. I].
Donatelli L
Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074
[No Abstract] [Full Text] [Related]
10. A comparison of hypolipidemic drugs in the prevention of an orotic acid fatty liver.
Elwood JC; Richert DA; Westerfeld WW
Biochem Pharmacol; 1972 Apr; 21(8):1127-34. PubMed ID: 5034198
[No Abstract] [Full Text] [Related]
11. Potential hypolipidemic agents. XIV. Synthesis and plasma lipid-lowering properties of substituted biphenyls, diphenyl ethers and benzofurans related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate.
Bondesson G; Högberg T; Misiorny A; Stjernström NE
Acta Pharm Suec; 1976; 13(2):97-106. PubMed ID: 937013
[No Abstract] [Full Text] [Related]
12. Synthesis and hypolipidemic evaluation of beta-alkylaminopropiophenone and beta-alkylaminopropio-2'-naphthone derivatives in rodents.
Huang Y; Hall IH
Pharmazie; 1996 Apr; 51(4):199-206. PubMed ID: 8628737
[TBL] [Abstract][Full Text] [Related]
13. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
Moody DE; Reddy JK
Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
[No Abstract] [Full Text] [Related]
14. [Biochemical and experimental aspects of the lipid-lowering drugs pharmacology (author's transl)].
Jacotot B
Sem Hop; 1979 Dec 8-15; 55(41-42):1947-55. PubMed ID: 231322
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of action of drugs affecting lipid metabolism].
Rossini L
Minerva Med; 1975 Oct; 66(66):3458-68. PubMed ID: 1178137
[No Abstract] [Full Text] [Related]
16. Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
Högberg T; Bondesson G; Stjernström NE
Acta Pharm Suec; 1977; 14(2):149-60. PubMed ID: 906832
[No Abstract] [Full Text] [Related]
17. The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.
Rodney G; Uhlendorf P; Maxwell RE
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):6-10. PubMed ID: 828263
[No Abstract] [Full Text] [Related]
18. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
Tomita T; Takeshita R; Nagakura T; Hayashi E
Jpn J Pharmacol; 1973 Jun; 23(3):281-7. PubMed ID: 4541943
[No Abstract] [Full Text] [Related]
19. [Measurements of regional brain blood flow using xenon 133 before and after intravenous administration of the so-called vasoactive and cerebral-metabolism-active drugs in acute experiment].
Kohlmeyer K
Verh Dtsch Ges Kreislaufforsch; 1973; 39():96-101. PubMed ID: 4785972
[No Abstract] [Full Text] [Related]
20. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
Barnard SD; Molello JA; Caldwell WJ; Lebeau JE
Nouv Presse Med; 1980 Oct; 9(40):3005-7. PubMed ID: 7443440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
